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Introduction
The glycolytic enzyme 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase, isoform 3
(PFKFB3) has been shown to be an effective target in angiogenic models by reducing the
migration and proliferation of endothelial cells (ECs) and thus angiogenesis. Matrix-degrading
metalloproteases (MMPs) play an essential role in angiogenesis as they degrade extracellular
matrix components to enable endothelial cell (EC) migration.
We studied the in vitro effects of the commercially available PFKFB3 inhibitor, 3-(3-pyridinyl)-1-
(4-pyridinyl)-2-propen-1-one (3PO), and newly designed PFKFB3-binding compounds on MMP
activity and wound-healing capacity.
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Aim
To	investigate	the	effect	of	novel	PFKFB3-binding	compounds	on	
endothelial	migration,	proliferation	and	angiogenesis.	
Following	this,	we	will	examine	the	pharmaceutical	potential	of	
PFKFB3	blockage	on	atherosclerotic	plaque	progression	and	
stability.	
Conclusion
Novel	compounds,	such	as		PA2	efficiently	inhibit	
endothelial	migration,	therefore	having	a	potential	to	be	
used	as	inhibitors	of	angiogenesis,	a	process	detrimental	
for	atherosclerotic	plaque	stability.		
Additionally,	targeting	PFKFB3	offers	a	gateway	to	
reduce	MMP	activity	and	consequently	stabilize	
atherosclerotic	plaques.	
Decreased	MMP-9	and	MMP-2	activity	in	Endothelial	Cells	by	PFKFB3-binding	compounds
Inhibition	of	wound	closure	of	Endothelial	Cells	by	PFKFB3-binding	compounds
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